Financials Haleon Pakistan Limited

Equities

HALEON

PK0112101016

Pharmaceuticals

End-of-day quote Pakistan S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
254.5 PKR +0.98% Intraday chart for Haleon Pakistan Limited +3.88% +50.58%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 30,986 25,454 30,015 31,035 28,217 19,185
Enterprise Value (EV) 1 29,684 26,338 30,139 29,139 25,129 15,905
P/E ratio 43.8 x 29 x 23.9 x 24.6 x 13.2 x 59 x
Yield 1.54% 1.88% 1.95% 1.89% - -
Capitalization / Revenue 3.73 x 1.71 x 1.84 x 1.56 x 1.17 x 0.7 x
EV / Revenue 3.58 x 1.77 x 1.85 x 1.47 x 1.04 x 0.58 x
EV / EBITDA 29 x 14.9 x 14.2 x 14.1 x 7.84 x 11.9 x
EV / FCF 56.9 x -66.6 x 26.9 x 12.1 x 18.3 x 23.5 x
FCF Yield 1.76% -1.5% 3.72% 8.25% 5.46% 4.26%
Price to Book 13.5 x 8.13 x 6.67 x 6.01 x 4.2 x 2.72 x
Nbr of stocks (in thousands) 95,550 95,550 117,055 117,055 117,055 117,055
Reference price 2 324.3 266.4 256.4 265.1 241.1 163.9
Announcement Date 3/8/18 4/2/19 4/29/20 3/31/21 2/28/22 4/6/23
1PKR in Million2PKR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 8,298 14,875 16,317 19,846 24,163 27,507
EBITDA 1 1,024 1,773 2,115 2,067 3,204 1,335
EBIT 1 1,001 1,562 1,884 1,799 2,903 1,010
Operating Margin 12.06% 10.5% 11.54% 9.06% 12.01% 3.67%
Earnings before Tax (EBT) 1 1,171 1,463 1,700 1,774 3,016 992.8
Net income 1 706.8 1,075 1,258 1,262 2,134 325.4
Net margin 8.52% 7.22% 7.71% 6.36% 8.83% 1.18%
EPS 2 7.397 9.180 10.74 10.78 18.23 2.780
Free Cash Flow 1 521.9 -395.3 1,120 2,404 1,373 676.8
FCF margin 6.29% -2.66% 6.86% 12.11% 5.68% 2.46%
FCF Conversion (EBITDA) 50.96% - 52.94% 116.3% 42.84% 50.71%
FCF Conversion (Net income) 73.83% - 89.04% 190.49% 64.31% 208%
Dividend per Share 2 5.000 5.000 5.000 5.000 - -
Announcement Date 3/8/18 4/2/19 4/29/20 3/31/21 2/28/22 4/6/23
1PKR in Million2PKR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 884 124 - - -
Net Cash position 1 1,302 - - 1,895 3,088 3,281
Leverage (Debt/EBITDA) - 0.4989 x 0.0587 x - - -
Free Cash Flow 1 522 -395 1,120 2,404 1,373 677
ROE (net income / shareholders' equity) 36.3% 35% 30.2% 26.1% 35.9% 4.73%
ROA (Net income/ Total Assets) 18.4% 16.4% 13.9% 11.3% 14.6% 4.36%
Assets 1 3,849 6,554 9,045 11,202 14,610 7,455
Book Value Per Share 2 24.00 32.80 38.40 44.10 57.40 60.20
Cash Flow per Share 2 11.50 6.040 5.500 18.20 21.00 21.40
Capex 1 28.4 315 525 851 543 503
Capex / Sales 0.34% 2.12% 3.22% 4.29% 2.25% 1.83%
Announcement Date 3/8/18 4/2/19 4/29/20 3/31/21 2/28/22 4/6/23
1PKR in Million2PKR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. HALEON Stock
  4. Financials Haleon Pakistan Limited